GVAX pancreatic cancer vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GVAX pancreatic cancer vaccine, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas [EARLY_Phase 1]